These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8910299)

  • 21. An improved method for heterozygote identification in feline and human mucopolysaccharidosis VI, arylsulfatase-B deficiency.
    McGovern MM; Vine DT; Haskins ME; Desnick RJ
    Enzyme; 1981; 26(4):206-10. PubMed ID: 6113958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.
    Fillat C; Simonaro CM; Yeyati PL; Abkowitz JL; Haskins ME; Schuchman EH
    J Clin Invest; 1996 Jul; 98(2):497-502. PubMed ID: 8755662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats.
    Turner CT; Hopwood JJ; Bond CS; Brooks DA
    Mol Genet Metab; 1999 Jul; 67(3):194-205. PubMed ID: 10381327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of fibroblast-mediated gene therapy in a feline model of mucopolysaccharidosis type VI.
    Yogalingam G; Crawley A; Hopwood JJ; Anson DS
    Biochim Biophys Acta; 1999 Feb; 1453(2):284-96. PubMed ID: 10036326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical characterization of feline and human N-acetylgalactosamine 4-sulfatase.
    Brooks DA; Gibson GJ; Hopwood JJ
    Biochem Med Metab Biol; 1994 Oct; 53(1):58-66. PubMed ID: 7857682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary molecular analysis of a case of feline mucopolysaccharidosis VI.
    De Luca T; Minichiello L; Leone A; Di Natale P
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1177-82. PubMed ID: 7504466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of a human lysosomal sulfatase.
    Bond CS; Clements PR; Ashby SJ; Collyer CA; Harrop SJ; Hopwood JJ; Guss JM
    Structure; 1997 Feb; 5(2):277-89. PubMed ID: 9032078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts.
    Taylor JA; Gibson GJ; Brooks DA; Hopwood JJ
    Biochem J; 1990 Jun; 268(2):379-86. PubMed ID: 2114091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats.
    Auclair D; Finnie J; Walkley SU; White J; Nielsen T; Fuller M; Cheng A; O'Neill CA; Hopwood JJ
    Pediatr Res; 2012 Jan; 71(1):39-45. PubMed ID: 22289849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme replacement therapy in a feline model of MPS VI: modification of enzyme structure and dose frequency.
    Byers S; Crawley AC; Brumfield LK; Nuttall JD; Hopwood JJ
    Pediatr Res; 2000 Jun; 47(6):743-9. PubMed ID: 10832731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel arylsulfatase B gene mutation in three unrelated Iranian mucopolysaccharidosis type-VI patients with different phenotype severity.
    Nouri N; Nouri N; Aryani O; Kamalidehghan B; Houshmand M
    Iran Biomed J; 2012; 16(3):169-71. PubMed ID: 23023219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models.
    Brooks DA; King BM; Crawley AC; Byers S; Hopwood JJ
    Biochim Biophys Acta; 1997 Aug; 1361(2):203-16. PubMed ID: 9300802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.
    Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL
    Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme.
    Bielicki J; Hopwood JJ; Wilson PJ; Anson DS
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):241-6. PubMed ID: 8424762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1.
    Jackson CE; Yuhki N; Desnick RJ; Haskins ME; O'Brien SJ; Schuchman EH
    Genomics; 1992 Oct; 14(2):403-11. PubMed ID: 1427856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI).
    Uttarilli A; Pasumarthi D; Ranganath P; Dalal AB
    Gene; 2017 Jan; 599():19-27. PubMed ID: 27826022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.
    Petry MF; Nonemacher K; Sebben JC; Schwartz IV; Azevedo AC; Burin MG; de Rezende AR; Kim CA; Giugliani R; Leistner-Segal S
    J Inherit Metab Dis; 2005; 28(6):1027-34. PubMed ID: 16435196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association.
    Vine DT; McGovern MM; Schuchman EH; Haskins ME; Desnick RJ
    J Clin Invest; 1982 Feb; 69(2):294-302. PubMed ID: 6799547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry.
    Crawley A; Ramsay SL; Byers S; Hopwood J; Meikle PJ
    Pediatr Res; 2004 Apr; 55(4):585-91. PubMed ID: 14711884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein.
    Brooks DA; Robertson DA; Bindloss C; Litjens T; Anson DS; Peters C; Morris CP; Hopwood JJ
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):457-63. PubMed ID: 7733883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.